Delivery Order SPE2DB20D3103-SPE2DB23FL5V9
- Not listed
- This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,804.82 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 6, 2025. This award is not associated with a...
- This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract. The $5,464.80 award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 12, 2024, with a completion date of June 13, 2024. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,413.30, is a delivery order for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML medication to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order has a ceiling value of $1,036.42 and is set to be completed by June 5, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug...
- This federal contract award, valued at $2,456.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- This federal contract award, valued at $2,027.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a completion date of June 7, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price of $1,365.90 and a completion date of May 19, 2022. The contract is a delivery order, and there was no set-aside designation, indicating it was a full and open competition....
- The federal contract award, with an ID of SPE2DB20D2104|SPE2DB23FS88B, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,254.12 contract is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency within the U.S. government. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,884.40, is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., doing business as Amerisourcebergen. The contract is a Delivery Order with a Firm Fixed Price of $2,824.94 and an Ultimate Completion Date of January 4, 2022. This award is not designated as a set-aside contract. Amerisourcebergen is a major...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL5V9Delivery Order
This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 9, 2022, with a ceiling value of $2,277.00 and a completion date of November 10, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/9/22 |